novel
seri
ribonucleosid
synthes
kabachnikfield
reaction
use
catalyst
follow
coppercatalyz
cycloaddit
azidealkyn
reaction
cuaac
structur
newli
prepar
compound
character
h
nmr
c
nmr
hrm
spectra
structur
confirm
xray
diffract
analysi
compound
test
variou
strain
dna
rna
virus
compound
show
modest
inhibitori
activ
respiratori
syncyti
viru
rsv
compound
display
modest
inhibitori
activ
coxsacki
viru
current
human
be
world
suffer
differ
kind
diseas
caus
dna
rna
virus
diseas
mostli
diagnos
difficult
cure
vaccin
reliabl
tool
fight
viral
diseas
avail
virus
difficulti
associ
nation
worldwid
vaccin
program
make
antivir
chemotherapi
even
practic
approach
fight
epidem
viral
infect
nucleosid
analog
synthet
compound
structur
similar
natur
nucleosid
serv
build
block
dna
rna
act
competit
inhibitor
viral
cellular
dna
rna
polymeras
altern
incorpor
grow
dna
rna
strand
caus
chain
termin
aaminophosphon
defin
structur
analog
natur
amino
acid
consid
import
class
compound
divers
interest
biolog
activ
aminophosphon
describ
anticanc
agent
enzym
inhibitor
peptid
mimet
antibiot
pharmacolog
agent
also
correspond
prof
joachim
w
engel
institut
organ
chemistri
chemic
biolog
goetheunivers
frankfurt
main
maxvonlauestrass
frankfurt
main
germani
email
joachimengel
chemieunifrankfurtd
fax
report
interest
carrier
transport
hydrophil
molecul
across
bilay
lipid
membran
aaminophosphon
deriv
often
synthes
via
kabachnikfield
reaction
coupl
carbonyl
compound
amin
hydroxyphosphoryl
compound
use
variou
catalyst
prepar
huisgen
use
cycloaddit
reaction
acetylen
approxim
four
decad
reaction
acquir
consider
attent
owe
introduct
copper
catalyst
medal
sharpless
coppercatalyz
cycloaddit
azid
alkyn
cuaac
also
known
click
chemistri
offer
simpl
access
short
reaction
time
nucleosid
contain
ring
special
interest
drug
develop
research
synthet
triazol
display
interest
biolog
activ
sever
analog
test
hepat
c
virus
moreov
nucleosid
acyclonucleosid
analog
contain
phosphon
structur
describ
potent
antivir
agent
herein
describ
synthesi
novel
hybrid
molecul
contain
triazolylnucleosid
link
aaminophosphon
phenyl
ring
choic
structur
base
combin
pharmacophor
part
phenyltriazolylribosid
aaminophosphon
known
signific
pharmacolog
properti
synthesi
strategi
base
use
two
reaction
kabachnickfield
reaction
cycloaddit
compound
obtain
test
select
dna
rna
virus
synthesi
desir
compound
depict
scheme
initi
aaminophosphon
compound
prepar
good
yield
via
kabachnikfield
reaction
trimethylsilyl
ethynyl
benzaldehyd
react
diethylphosphit
correspond
amin
acetonitril
use
molecular
iodin
catalyst
latter
lowpric
readili
avail
nonmetal
nontox
mixtur
stir
room
temperatur
h
get
compound
next
step
deprotect
trimethylsilyl
group
purpos
tetrabutylammonium
fluorid
tbaf
tetrahydrofuran
thf
use
give
termin
alkyn
structur
confirm
xray
diffract
fig
accord
crystal
data
structur
similar
compound
pc
bond
stagger
conform
two
sixmemb
group
respect
p
doubl
bond
two
benzen
ring
almost
perpendicular
four
compound
crystal
structur
molecul
arrang
centrosymmetr
pseudocentrosymmetr
dimer
relat
two
p
hydrogen
bond
hand
crystal
structur
hydrogen
bond
p
found
molecul
arrang
centrosymmetr
dimer
link
c
methyl
p
hydrogen
bond
next
prepar
use
cycloaddit
reaction
termin
alkyn
bazidoribos
coupl
use
cu
alkyneazid
cycloaddit
basic
medium
triethylamin
reaction
carri
microwav
irradi
microwav
heat
shown
increas
reaction
yield
speed
reaction
time
bazidoribos
slightli
unstabl
microwav
condit
use
excess
configur
anomer
carbon
retain
present
bazidoribos
hydroxyl
function
protect
benzoyl
group
prior
cuaac
reaction
order
increas
solubl
compound
structur
compound
confirm
basi
h
c
nmr
spectra
well
highresolut
mass
spectrometri
h
nmr
spectra
intermedi
triazol
proton
appear
singlet
aromat
region
anomer
proton
appear
multiplet
around
ppm
last
step
involv
remov
benzoyl
protect
group
posit
dribos
use
sodium
methoxid
naom
methanol
afford
desir
nucleosid
tabl
antivir
activ
synthes
compound
test
differ
virus
cell
cultur
herp
simplex
ko
strain
herp
simplex
g
strain
thymidin
kinas
defici
acyclovirresist
tk
ko
acv
r
vaccinia
viru
vesicular
stomat
viru
vsv
varicella
product
character
h
nmr
c
nmr
mass
spectrometri
b
yield
isol
product
cuaac
reaction
c
yield
isol
product
protect
reaction
influenza
subtyp
influenza
subtyp
influenza
b
viru
mdck
madindarbi
canin
kidney
cell
follow
refer
compound
includ
tenofovir
pmpa
ganciclovir
cidofovir
acyclovir
brivudin
lectin
hippeastrum
hybrid
agglutinin
hha
urtica
dioica
agglutinin
uda
dextran
sulfat
molecular
weight
ribavirin
oseltamivir
carboxyl
amantadin
rimantadin
zalcitabin
alovudin
antivir
activ
express
ec
compound
concentr
requir
reduc
virusinduc
cytopathogen
viral
plaqu
format
cytotox
test
compound
toward
uninfect
host
cell
defin
minimum
cytotox
concentr
mcc
caus
microscop
detect
alter
normal
cell
morpholog
cytotox
concentr
cc
caus
decreas
cell
viabil
determin
use
colorimetr
mt
assay
system
test
compound
display
antivir
activ
differ
virus
test
except
compound
show
slight
inhibit
respiratori
syncyti
viru
replic
tabl
compound
display
weak
activ
tk
tk
vzv
strain
see
support
inform
although
compound
activ
coxsacki
viru
vero
cell
cultur
activ
seen
hela
cell
tabl
seri
novel
ribosid
link
aaminophosphon
success
prepar
high
yield
via
kabachnikfield
reaction
cu
catalyz
alkyneazid
cycloaddit
microwav
irradi
synthes
compound
evalu
broad
rang
dna
rna
virus
show
modest
activ
respiratori
syncyti
viru
compound
varicellazost
viru
compound
reaction
carri
microwav
oven
model
reaction
monitor
thin
layer
chromatographi
tlc
precoat
silica
gel
merck
darmstadt
germani
uv
light
use
visual
spot
product
purifi
column
chromatographi
silica
gel
mesh
merck
c
nmr
spectra
record
bruker
mhz
spectromet
respect
sime
use
intern
standard
chemic
shift
given
ppm
coupl
constant
j
mhz
multipl
report
singlet
doublet
triplet
q
quartet
multiplet
mass
spectra
produc
esim
malditofm
gener
procedur
synthesi
diethyl
trimethylsilyl
ethynyl
phenyl
aryl
alkylamino
methyl
phosphon
compound
synthes
reaction
commerci
sigmaaldrich
trimethylsilyl
ethynyl
benzaldehyd
mmol
diethylphosphit
equiv
correspond
amin
equiv
acetonitril
ml
use
molecular
iodin
equiv
catalyst
room
temperatur
reaction
mixtur
stir
room
temperatur
h
solvent
remov
reduc
pressur
result
residu
purifi
column
chromatographi
use
ethyl
acetatehexan
eluent
gener
procedur
synthesi
diethyl
aryl
alkylamino
phenyl
methyl
phosphon
trimethylsilyl
ethynyl
phenyl
aaminophosphon
mmol
react
tetrabutylammonium
fluorid
equiv
tetrahydrofuran
ml
min
stir
room
temperatur
reaction
mixtur
purifi
silica
gel
column
chromatographi
get
ethynyl
phenyl
aaminophosphon
termin
alkyn
mmol
bazidoribos
equiv
triethyl
amin
equiv
mix
cui
equiv
reaction
mixtur
homogen
dri
acetonitril
ml
stir
min
solvent
evapor
vacuum
reaction
mixtur
irradi
power
level
w
min
residu
purifi
silica
gel
use
ethyl
acetatehexan
eluent
